# EDGAR Filing Document

**Accession Number:** 0001140859
**File Stem:** 0001140859-23-000077
**Filing Date:** 2023-3
**Character Count:** 8962
**Document Hash:** f9113907943a03d92ecf8fc409ad99da
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140859-23-000077.hdr.sgml**: 20230315

**ACCESSION NUMBER**: 0001140859-23-000077

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20230309

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**ITEM INFORMATION**: Other Events

**FILED AS OF DATE**: 20230315

**DATE AS OF CHANGE**: 20230315

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AMERISOURCEBERGEN CORP
- **CENTRAL INDEX KEY:** 0001140859
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
- **IRS NUMBER:** 233079390
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-16671
- **FILM NUMBER:** 23735214

**BUSINESS ADDRESS:**
- **STREET 1:** 1 WEST FIRST AVENUE
- **CITY:** CONSHOHOCKEN
- **STATE:** PA
- **ZIP:** 19428
- **BUSINESS PHONE:** 6107277000

**MAIL ADDRESS:**
- **STREET 1:** 1 WEST FIRST AVENUE
- **CITY:** CONSHOHOCKEN
- **STATE:** PA
- **ZIP:** 19428

?xml version="1.0" ? abc-20230309

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

_________________________________

**FORM 8-K** 

_________________________________

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): March 9, 2023

&nbsp;&nbsp;&nbsp;&nbsp;_________________________________

**AmerisourceBergen Corporation**

(Exact name of registrant as specified in its charter)

**_________________________________**

Commission File Number: **1-6671** 

---

| | | | |
|:---|:---|:---|:---|
| **Delaware** | **Delaware** | **Delaware** | **23-3079390** |
| (State or other jurisdiction of | (State or other jurisdiction of | (State or other jurisdiction of | (I.R.S. Employer |
| incorporation or organization) | incorporation or organization) | incorporation or organization) | Identification No.) |
| **1 West First Avenue** | **Conshohocken** | **PA** | **19428-1800** |
| (Address of principal executive offices) | (Address of principal executive offices) | (Address of principal executive offices) | (Zip Code) |

---

**(610) 727-7000** 

(Registrant's telephone number, including area code)

**Not Applicable**

(Former name or former address, if changed since last report.)

_________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

**☐** Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

**☐** Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

**☐** Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

**☐** Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | | |
|:---|:---|:---|:---|
| **<u>Title of each class</u>** | **<u>Trading Symbol(s)</u>** | **<u>Name of exchange on which registered</u>** | **<u>Name of exchange on which registered</u>** |
| Common stock | ABC | New York Stock Exchange | (NYSE) |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company **☐** 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

------

**Item 5.07. Submission of Matters to a Vote of Security Holders.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;AmerisourceBergen Corporation (the "Company") held its 2023 Annual Meeting of Shareholders (the "2023 Annual Meeting") on March 9, 2023.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Each of the five items listed below was submitted to a vote of the Company's shareholders at the 2023 Annual Meeting and is described in more detail in the definitive proxy statement filed by the Company with the Securities and Exchange Commission on January 27, 2023 (the "Definitive Proxy Statement"). The final voting results are set forth below:

<u>Item 1 - Election of Directors.</u>

Each of the individuals listed below was elected by the Company's shareholders to serve as a director until the 2024 Annual Meeting of Shareholders and until his or her successor is duly elected and qualified.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Nominees** | **For** | **Against** | **Abstentions** | **Broker Non-Votes** |
| Ornella Barra | 172416240 | 3063478 | 320957 | 10193326 |
| Steven H. Collis | 165850706 | 8888877 | 1061092 | 10193326 |
| D. Mark Durcan | 174260880 | 1226663 | 313132 | 10193326 |
| Richard W. Gochnauer | 168210389 | 7319850 | 270436 | 10193326 |
| Lon R. Greenberg | 172484891 | 3006291 | 309493 | 10193326 |
| Kathleen W. Hyle | 168948234 | 6530873 | 321568 | 10193326 |
| Lorence H. Kim, M.D. | 175165369 | 324890 | 310416 | 10193326 |
| Henry W. McGee | 165580691 | 9947738 | 272246 | 10193326 |
| Redonda G. Miller, M.D. | 175350294 | 179952 | 270429 | 10193326 |
| Dennis M. Nally | 174066904 | 1422067 | 311704 | 10193326 |

---

<u>Item 2 - Ratification of Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2023.</u>

The Company's shareholders approved this item. The voting results were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstentions** | **Broker Non-Votes** |
| 175,918,757 | 9,856,170 | 219,074 | N/A |

---

<u>Item 3 - Advisory Vote to Approve the Compensation of the Company's Named Executive Officers.</u>

The Company's shareholders approved this item. The voting results were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstentions** | **Broker Non-Votes** |
| 167,879,511 | 7,418,048 | 503,116 | 10,193,326 |

---

<u>Item 4 - Advisory Vote on the Frequency of a Shareholder Vote on the Compensation of the Company's Named Executive Officers.</u>

The Company's shareholders voted for holding an annual advisory vote on the compensation of the Company's named executive officers. The voting results were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **1 Year** | **2 Years** | **3 Years** | **Abstentions** | **Broker Non-Votes** |
| 173,594,566 | 85,242 | 1,839,786 | 281,081 | 10,193,326 |

---

------

<u>Item 5 - Shareholder Proposal Regarding Shareholder Ratification of Termination Pay.</u>

The Company's shareholders did not approve this item. The voting results were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstentions** | **Broker Non-Votes** |
| 15,064,251 | 160,009,226 | 727,198 | 10,193,326 |

---

No item other than the five items addressed above and described in the Definitive Proxy Statement was submitted at the 2023 Annual Meeting for shareholder action.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;As reported above, the Company's shareholders expressed a preference of "1 Year" for the frequency with which shareholder votes on named executive officer compensation should be held. In accordance with the recommendation of the Board of Directors of the Company (the "Board") set forth in the Definitive Proxy Statement and consistent with the stated preference of the majority of the Company's shareholders, future advisory shareholder votes on executive compensation will be conducted on an annual basis, until the next advisory vote on frequency is held. The next advisory vote regarding the frequency of say-on-pay votes is required to occur no later than the Company's 2029 Annual Meeting of Shareholders.

**Item 8.01. Other Events.**

As previously disclosed in the Definitive Proxy Statement, on March 9, 2023, D. Mark Durcan became Lead Independent Director of the Board, succeeding Jane E. Henney, M.D.

------

<u>SIGNATURES</u>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | | AMERISOURCEBERGEN CORPORATION | AMERISOURCEBERGEN CORPORATION |
| Date: | March 15, 2023 | By: | /s/ Elizabeth S. Campbell |
|  |  | Name: | Elizabeth S. Campbell |
|  |  | Title: | Executive Vice President & Chief Legal Officer |

---